Vyvanse 30 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DB25FGAJR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,305
Award facts
- Contract value 100% obligated
- $3,304.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $3,304.66 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Vyvanse 30 mg capsules (100-count units). The contract, designated as non-competitive and priced on a firm fixed-price basis, is scheduled for completion by August 4, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion pharmaceutical supply vehicle running through December 2026 that enables the company to distribute medications and medical supplies globally to support military healthcare operations.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal procurement presence primarily through its DLA relationships. The company's federal contract portfolio demonstrates extensive experience delivering brand-name and generic pharmaceuticals, specialty medications, and medical supplies across multiple therapeutic areas to military and veteran healthcare systems. This award for Vyvanse, a prescription medication commonly used in military populations, exemplifies the company's role as a critical vendor within the Defense Health Agency's medical supply chain and reflects the competitive capability AmerisourceBergen has established as a leading pharmaceutical prime vendor for Department of Defense medical procurement.
Quick answers
Who was awarded contract SPE2DB25FGAJR?
SPE2DB25FGAJR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FGAJR worth?
The government has obligated $3,305 on SPE2DB25FGAJR.
Is contract SPE2DB25FGAJR an order under another contract?
Yes. SPE2DB25FGAJR is a delivery order under SPE2DB24D3015, an indefinite delivery contract.
Was contract SPE2DB25FGAJR competed?
The extent of competition for SPE2DB25FGAJR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award